HemoCue AB - Point of Care Diagnostic Products
- Tel: +46 431 45 82 00
- Contact this Company »
- Visit Web Site »
Diagnostic Products for Point-of-Care Testing
HemoCue is a Quest Diagnostics company with sales of around EUR 65 million and more than 340 employees worldwide. The company is entirely dedicated to the development, marketing and distribution of diagnostic products for point-of-care testing. Its leading products measure hemoglobin and glucose in whole blood, and albumin in urine.
Factory Calibrated Instruments
The company has reached a market leader position with a product line of factory-calibrated instruments and a reagent component, a proprietary microcuvette, manufactured without batch-to-batch variation. This, in order to allow also non-laboratory personnel, to obtain lab accurate results, at point-of-care.
For additional information on the company, products or services visit: www.hemocue.com.
Contact:
HemoCue AB
Box 1204
SE-262 23 Angelholm
Sweden
Tel: +46 431 45 83 11
Fax: +46 431 45 82 25
Web: www.hemocue.com
Albumin 201 System
- Comparison of the HemoCue® Albumin 201 system with the albumin-to-creatnine-ratio method for urine albumin excretion determination »
Pantelis A. Sarafidis1, Jessica Riehle1, Emad Basta1, Atul Chugh1, and George L. Bakris2.
Diabetes
- 42nd Annual Meeting of the European Association for the Study of Diabetes »
HemoCue will arrange a symposium "Prediction and monitoring of cardiovascular and renal risk in diabetes".
Microalbuminuria Screening
- Primary Care and Microalbuminuria Screening »
Diabetes is on the rise, and with it devastating complications in the form of chronic kidney disease (CKD) and cardiovascular disease (CVD).
Data Management Systems
- 201 Data Management Systems »
HemoCue introduces point-of-care testing (POCT) devices with advanced Data Management capabilities.
Albuminuria
- HemoCue Albuminuria »
The HemoCue Albumin systems can be used for the quantitative determination of low levels of albumin in urine for the purpose of screening for, diagnosing, monitoring and supporting the clinical evidence in the treatment of microalbuminuria.
